Shoosmiths advises LDC on £11m investment into leading global medical communications group
June, 2017 - Thames Valley, England
National law firm Shoosmiths has advised LDC, the UK’s leading mid-market private equity investor, on its latest investment into Lucid Group Communications, a global specialist provider of strategic medical communications services to world leading pharmaceutical companies.
LDC completed an £11million minority investment into the group which has offices in London, Beaconsfield and New York City. Founded in 2007, the group provides medical education, medical communication, strategic consultancy and digital services to drive better disease and patient management.
LDC’s investment will enable Lucid to continue to build infrastructure to support its rapid growth, strengthen its market presence in the US and support Lucid in building its digital and creative capability to broaden support for clients. LDC investment directors Christian Bruning and Rob Apollo will join the board with Tim Trotter appointed as Non-Executive Chairman.
The Shoosmiths team was led by corporate partner Emma Gibson with Kiran Dhesi (Senior Associate) and James Skivington (Associate) assisting.
Christian Bruning, investment director at LDC in London, commented: ‘We are excited at the clear growth opportunities, both at home and overseas, that our investment into Lucid brings. Once again Shoosmiths has provided us with excellent legal advice combined with clear knowledge of our business aims that resulted in a swift and successful completion.’
Emma Gibson added: ‘We are extremely pleased to have advised LDC on their latest investment into the medical communications market. LDC’s financial support and expertise will ensure Lucid continue to be a success in a highly competitive and ever growing market and we wish them all the best with this on-going venture.’
Shoosmiths' corporate team advises public and private companies, management teams, investors and debt providers through the business life cycle. Shoosmiths work with businesses from start-up and first round finance through to mergers and acquisitions, MBO and MBI transactions, development funding and on exits, by way of sale, listing or private equity investment.
Nationally, the corporate team is ranked in first place by deal volume in Experian's 2016 MarketIQ UK & Ireland M&A league tables. The team was recognised for its mergers and acquisitions expertise at the 2015 M&A Awards, winning the Law Firm of the Year category.
